Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting KRAS in cancer
Anupriya Singhal, Bob T. Li, Eileen M. O’Reilly
Nature Medicine (2024) Vol. 30, Iss. 4, pp. 969-983
Closed Access | Times Cited: 67

Showing 26-50 of 67 citing articles:

Copper-KRAS-COX2 Axis: A Therapeutic Vulnerability in Pancreatic Cancer
Joyeeta Roy, Rima Mouawad, Armita Kyani, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Advocating for change—Integration of efforts across the drug discovery and development continuum
Timothy P. Heffernan, Giulio Draetta
Cancer Cell (2025)
Closed Access
Recent advances in therapeutic strategies for non-small cell lung cancer
Po‐Lan Su, Naoki Furuya, Atif Asrar, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access
PRMT5 inhibitors: Therapeutic potential in pancreatic cancer
Carolin Schneider, Valentina Spielmann, Christian Braun, et al.
Translational Oncology (2025) Vol. 55, pp. 102366-102366
Closed Access
Advances in the treatment of KRASG12C mutant non–small cell lung cancer
Khvaramze Shaverdashvili, Timothy F. Burns
Cancer (2025) Vol. 131, Iss. S1
Open Access
Covalent inhibitors possessing autophagy-modulating capabilities: charting novel avenues in drug design and discovery
Yutong Wang, Shiyu Luo, Hongbao Sun, et al.
Drug Discovery Today (2025), pp. 104347-104347
Closed Access
Road Map to Defeat Pancreatic Cancer
L. Paige Ferguson, David A. Tuveson
Annual Review of Cancer Biology (2025) Vol. 9, Iss. 1, pp. 1-20
Closed Access
Precision Oncology in Pancreatic Cancer and Future Treatment Directions
Layal Al Mahmasani, Eileen M. O’Reilly
Surgical Oncology Clinics of North America (2025)
Closed Access
Epidermal Growth Factor Receptor Targeting in Colorectal Carcinoma: Antibodies and Patient-Derived Organoids as a Smart Model to Study Therapy Resistance
Samuele Tardito, Serena Matis, Maria Raffaella Zocchi, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7131-7131
Open Access | Times Cited: 4
HRS-4642: The next piece of the puzzle to keep KRAS in check
Alejandra A. Flores-Gómez, Matthias Drosten
Cancer Cell (2024) Vol. 42, Iss. 7, pp. 1157-1159
Closed Access | Times Cited: 4
Emerging Targets in Non-Small Cell Lung Cancer
Louisa Liu, Joshua Soler, Karen L. Reckamp, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 18, pp. 10046-10046
Open Access | Times Cited: 4
USP13 facilitates a ferroptosis-to-autophagy switch by activation of the NFE2L2/NRF2-SQSTM1/p62-KEAP1 axis dependent on the KRAS signaling pathway
Ling Chen, Jieling Ning, Li Linghu, et al.
Autophagy (2024), pp. 1-18
Closed Access | Times Cited: 4
RAS signaling in carcinogenesis, cancer therapy and resistance mechanisms
Xiaojuan Yang, Hong Wu
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 4
The Current Role of Circulating Tumor DNA in the Management of Pancreatic Cancer
M.C. Cox, Dominic Vitello, Akhil Chawla
Journal of Gastrointestinal Cancer (2025) Vol. 56, Iss. 1
Closed Access
Chasing Red Herrings: Palladium Metal Salt Impurities Feigning KRAS Activity in Biochemical Assays
Thomas Gerstberger, Helmut Berger, Frank Büttner, et al.
Journal of Medicinal Chemistry (2024)
Closed Access | Times Cited: 3
Molecular classification of ovarian high-grade serous/endometrioid carcinomas through multi-omics analysis: JGOG3025-TR2 study
Shiro Takamatsu, R. Tyler Hillman, Kosuke Yoshihara, et al.
British Journal of Cancer (2024)
Closed Access | Times Cited: 3
Mechanisms of resistance to KRASG12C inhibitors in KRASG12C-mutated non-small cell lung cancer
Ali Chour, Anne‐Claire Toffart, E. Berton, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 3
Resistance to KRAS inhibition in advanced non-small cell lung cancer
Katherina Bernadette Sreter, Maria Joana Catarata, Maximilian von Laffert, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 2
Lead Identification of Novel Naphthyridine Derivatives as Potent SOS1 Inhibitors
Dongsheng Li, Qing Xie, Mao-Zhi Yang, et al.
ACS Medicinal Chemistry Letters (2024) Vol. 15, Iss. 6, pp. 958-964
Closed Access | Times Cited: 2
Exploring Predictive and Prognostic Biomarkers in Colorectal Cancer: A Comprehensive Review
Karam Ashouri, Alexandra C. Wong, Pooja Mittal, et al.
Cancers (2024) Vol. 16, Iss. 16, pp. 2796-2796
Open Access | Times Cited: 2
Targeting BCL2 with Venetoclax Enhances the Efficacy of the KRASG12D Inhibitor MRTX1133 in Pancreatic Cancer
Jeffrey H. Becker, Anastasia E. Metropulos, Christina Spaulding, et al.
Cancer Research (2024) Vol. 84, Iss. 21, pp. 3629-3639
Open Access | Times Cited: 2
Beyond KRAS(G12C): Biochemical and Computational Characterization of Sotorasib and Adagrasib Binding Specificity and the Critical Role of H95 and Y96
Randa Mahran, Jonas N. Kapp, Salla Valtonen, et al.
ACS Chemical Biology (2024) Vol. 19, Iss. 10, pp. 2152-2164
Closed Access | Times Cited: 2
The role of metabolic reprogramming in liver cancer and its clinical perspectives
Mengxiao Lu, Yingjie Wu, Min Xia, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 2
Triple Blockade of Oncogenic RAS Signaling Using KRAS and MEK Inhibitors in Combination with Irradiation in Pancreatic Cancer
XUAN WANG, Judith Breuer, Stephan Garbe, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 6249-6249
Open Access | Times Cited: 1
Innovative Therapeutic Approaches Targeting K-Ras: Analysis of Macrocyclic Compounds, Peptidomimetics, and Pyridopyrimidine Inhibitors
Robert B. Kargbo
ACS Medicinal Chemistry Letters (2024) Vol. 15, Iss. 8, pp. 1196-1198
Open Access | Times Cited: 1

Scroll to top